## EG: Everest Group, Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -4.4% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($295.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Invesco Ltd. Trims Stock Holdings in Everest Group, Ltd. $EG**
- Source: MarketBeat | 20251208T120824 | Neutral | Relevance: 98%
- Invesco Ltd. reduced its stake in Everest Group, Ltd. (NYSE:EG) by 16.5% during the second quarter, selling 134,371 shares. Despite Invesco's reduction, several other hedge funds increased their holdings in Everest Group. The company recently reported earnings that missed analyst expectations but announced a quarterly dividend of $2.00 per share.

**2. Amundi Cuts Stock Position in Everest Group, Ltd. $EG**
- Source: MarketBeat | 20251209T080808 | Neutral | Relevance: 98%
- Amundi reduced its stake in Everest Group, Ltd. (NYSE:EG) by 2.8% during the second quarter, selling 4,997 shares. Despite this, other institutions like Banco Bilbao Vizcaya Argentaria S.A. and Farther Finance Advisors LLC increased their positions. Everest Group reported mixed financial results, missing EPS estimates but exceeding revenue expectations, and announced a quarterly dividend.

**3. Nordic Recognized as Major Contender in Healthcare IT Services by Everest Group**
- Source: Yahoo Finance | 20251208T180839 | Neutral | Relevance: 98%
-  Nordic, a global health and technology consulting company, has been named a Major Contender in Everest Group's Healthcare Specialists IT Services PEAK Matrix Assessment 2025. This recognition highlights Nordic's vision, capabilities, and market impact in the healthcare IT sector, underscoring its 15-year history of expanding offerings to meet healthcare systems' evolving needs. The company's focus on end-to-end strategic partnership helps clients operationalize and innovate through core technologies and data strategies.

**4. Did Everest’s New Risk and Actuarial Leadership Team Quietly Recast EG’s Technical Edge?**
- Source: Simply Wall Street | 20251208T100812 | Somewhat-Bullish | Relevance: 98%
-  Everest Group has appointed Katy Bradica as Group Chief Actuary and Attila Kerényi as Group Chief Chief Risk Officer, signaling a stronger emphasis on technical underwriting and capital-efficient growth. These appointments are expected to influence how Everest balances growth in property catastrophe with tighter risk controls and capital allocation, especially under the leadership of CEO Jim Williamson. The article suggests this leadership change is crucial for supporting the company's growth thesis amidst increasing property catastrophe exposure and competitive pressures.

**5. SageView Advisory Group LLC Invests $1.70 Million in Everest Group, Ltd. $EG**
- Source: MarketBeat | 20251207T112612 | Neutral | Relevance: 98%
- SageView Advisory Group LLC has invested approximately $1.70 million in Everest Group, Ltd. (NYSE:EG) by purchasing 5,126 shares. This new position contributes to the 92.64% institutional ownership of the stock, despite recent analyst downgrades to a "Hold" rating and a missed quarterly EPS forecast. Directors Allan Levine and William F. Galtney Jr. also made significant insider purchases, increasing their holdings in the company.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (-1.0%)
- Blackrock Inc.: 8.1% (-2.9%)
- AQR Capital Manageme: 4.8% (+70.3%)
- State Street Corpora: 4.5% (-0.7%)
- Vulcan Value Partner: 3.4% (+13.9%)

### Key Risks

1. Long-term trend broken: trading 9.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Forward P/E 5.5x attractive for 25% earnings growth. Balance sheet: strong liquidity (11.3x). Revenue declining -6% YoY, concerning. Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.9B |
| Beta | 0.38 |
| 52W Range | $302.44 - $375.25 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -50.00 |
| Forward P/E | 5.5 |
| Current P/E | 6.9 |
| YoY Growth | 24.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 8.4pp (needs >4.0% for momentum thesis). Underperforming sector by 3.9pp, stock-specific weakness. Below SMA200 (0.91x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.42% (CS: 20) | Weak |
| RSI_14 | 38.2 | Neutral |
| MACD Histogram | 0.42 | Bullish |
| vs SMA20 | 0.976x | Below |
| vs SMA50 | 0.932x | Below |
| vs SMA200 | 0.906x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $308.40
- **Stop Loss:** $295.42 (4.2% risk)
- **Target:** $321.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $23,746.80
- **Portfolio %:** 23.75%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-02 (Est: $13.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $14.52 | $7.54 | -48.1% |
| 2025Q2 | $14.82 | $17.36 | +17.1% |
| 2025Q1 | $7.74 | $6.45 | -16.7% |
| 2024Q4 | $-17.42 | $-18.39 | -5.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*